Hendrik Rathke
- Oncology top 1%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 2%
- Surgery top 5%
- Co-authors
- Clemens KratochwilFrederik L. GieselUwe HaberkornFrank BruchertseiferAliyah MorgensternJürgen DebusManuel RöhrichThomas Lindner
- Topics
- Radiopharmaceutical Chemistry and Applications (24 papers)Prostate Cancer Treatment and Research (21 papers)Peptidase Inhibition and Analysis (19 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Hendrik Rathke
52 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 2.0k
- Radiology, Nuclear Medicine and Imaging 1.7k
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 880
- Surgery 817
Countries citing papers authored by Hendrik Rathke
This map shows the geographic impact of Hendrik Rathke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Rathke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Rathke more than expected).
Fields of papers citing papers by Hendrik Rathke
This network shows the impact of papers produced by Hendrik Rathke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Rathke. The network helps show where Hendrik Rathke may publish in the future.
Co-authorship network of co-authors of Hendrik Rathke
This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Rathke. A scholar is included among the top collaborators of Hendrik Rathke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Rathke. Hendrik Rathke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 31 | |
| 7 | 30 | |
| 8 | 42 | |
| 9 | 39 | |
| 10 | 60 | |
| 11 | 48 | |
| 12 | 15 | |
| 13 | 48 | |
| 14 | 69 | |
| 15 | 44 | |
| 16 | Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Controlbreakdown → | 314 |
| 17 | 64 | |
| 18 | Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Findingbreakdown → | 378 |
| 19 | 3 | |
| 20 | 5 |
About Hendrik Rathke
Hendrik Rathke is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research, having authored 52 papers that have together received 3.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (24 papers), Prostate Cancer Treatment and Research (21 papers) and Peptidase Inhibition and Analysis (19 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.7k citations), Oncology (2.0k citations) and Cancer Research (880 citations). Hendrik Rathke has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Clemens Kratochwil, Frederik L. Giesel, Uwe Haberkorn, Frank Bruchertseifer, Aliyah Morgenstern, Jürgen Debus, Manuel Röhrich, Thomas Lindner, Walter Mier and Paul Flechsig. Their work appears in journals such as Journal of Clinical Oncology, European Urology and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.